DEA Reports Significant Uptick in Marijuana-Related Seizures, Arrests

NORML

The post DEA Reports Significant Uptick in Marijuana-Related Seizures, Arrests appeared first on NORML. LAW ENFORCEMENT DEA eradictaion law enforcement seizures suppression

DEA 167

DEA Announces Intent to License Marijuana Growing Applicants

NORML

The DEA’s website did not provide a timeline as to when it anticipates finalizing the applicants’ grow authorizations or when it plans to take actions on the dozens of remaining applications that are still pending before the agency.

DEA 207
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

DEA: Marijuana Plant Seizures Spike, Arrests Fall in 2019

NORML

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 In 2011, for instance, the DEA seized over 8.7

DEA 237

DEA Report: Marijuana Seizures at Southern Border Have Fallen Significantly Following Passage of Statewide Legalization Laws

NORML

The post DEA Report: Marijuana Seizures at Southern Border Have Fallen Significantly Following Passage of Statewide Legalization Laws appeared first on NORML. LAW ENFORCEMENT DEA Mexico seizures southern border

DEA 208

NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules

NORML

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received.

DEA 270

DEA finally ends fed monopoly on schwaggy research-grade cannabis

Leafly

The post DEA finally ends fed monopoly on schwaggy research-grade cannabis appeared first on Leafly. Politics cannabis quality cannabis research DEA nida schwagGoodbye, Mississippi ditch weed. Hello, real-world high-quality cannabis.

DEA 114

New lawsuit aims to force DEA to reschedule marijuana

Leafly

The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly.

DEA 114

DEA Report: Fewer Marijuana Seizures, But More Arrests In 2018

NORML

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 However, while the total number of DEA-seized plants fell in 2018, seizures of indoor cannabis plants nearly doubled – rising from 304,000 plants in 2017 to just under 600,000 in 2018. LAW ENFORCEMENT assets DEA eradication legalization seizures

DEA 168

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. FDA GOVERNMENT SCIENCE DEA medical research University of Mississippi

DEA 167

NORML Comments on Biden’s Pick for DEA Administrator

NORML

The post NORML Comments on Biden’s Pick for DEA Administrator appeared first on NORML. Former NJ Attorney General to be Nominated to Lead Agency. LAW ENFORCEMENT Federal milgram nominee

DEA 144

DEA Press Release Implies More International Enforcement

Cannabis Law Report

The language is general but it looks like the DEA will be trying to nip supply in the bud at source. As part of the review, the team will talk to DEA personnel posted in DEA’s foreign offices and headquarters who perform this critical work.

DEA 87

Protestors of psilocybin ban arrested at DEA headquarters

Leafly

Many were arrested protesting the DEA's decision to not recognize the Right To Try law, allowing psilocybin use for terminally ill patients looking to ease end-of-life anxiety and distress. The post Protestors of psilocybin ban arrested at DEA headquarters appeared first on Leafly.

DEA 72

DEA Calls for Increases in Research-Grade Cannabis and Psychedelic Production

Veriheal

Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies. After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production.

DEA 77

DEA Letter – Delta 8 THC derived from hemp is not a controlled substance

Cannabis Life Network

In a recently obtained letter, the DEA clarified its position on hemp-derived Delta 8 THC. The post DEA Letter – Delta 8 THC derived from hemp is not a controlled substance appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

DEA 81

DEA Report: Federal Cannabis Arrests Drop Again.

Cannabis Law Report

While there were still 2,576 Drug Enforcement Administration (DEA) marijuana arrests in fiscal year 2020, cannabis busts have dropped an average of 11 percent each year since 2010, when DEA made 8,215 such arrests. Marijuana Moment reports.

DEA 56

Why the DEA Hemp Rule Challenge Really Matters. A Lot.

Canna Law Blog

The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. Challenging the DEA hemp rule. This was not the case with the DEA hemp rule, which was effective immediately.

DEA 75

DEA Seed Letter – Triumph or Trap?

Cannabis Law Report

Since the DEA’s Seed Letter became public I have fielded a number of calls from clients about selling cannabis seeds. The answer is, “It depends” Continue reading “DEA Seed Letter – Triumph or Trap?”

DEA 56

Why the DEA Hemp Rule Challenge Really Matters

Canna Law Blog

The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. Challenging the DEA hemp rule. This was not the case with the DEA hemp rule, which was effective immediately.

DEA 71

DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease

The Fresh Toast

DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease. The DEA application process is being delayed for years for reasons unknown. Medical Marijuana News DEA Huntington’s Disease multiple sclerosis

DEA 65

Analyses: Drug Interdiction Efforts at US Borders Typically Yield Only Small Quantities of Marijuana

NORML

LAW ENFORCEMENT border patrol DEA law enforcement seizures TexasDrug interdiction efforts along the US border often involve the seizure of small quantities of marijuana and no other substances, according to a pair of recently issued reports.

DEA 178

Hemp Litigation: DEA Sued Again

Canna Law Blog

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.

DEA 80

Weed seeds may be legal to ship across the US, DEA says

Leafly

Cali bud could end up on the East Coast easier than you think, according to a new official determination from the DEA. The post Weed seeds may be legal to ship across the US, DEA says appeared first on Leafly.

DEA 86

CVS Ignores DEA, Says It’s Already Selling CBD Products

Leafly

The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.

DEA 88

Hemp Trade Association, Seller Lose Legal Challenge to DEA Rule

Cannabis Law Report

Only appeals courts may hear challenges to DEA determinations, findings, and conclusions under the Controlled Substances Act, Judge Karen LeCraft Henderson of the US Court of Appeals for the D.C. Bloomberg. Hemp Industries Association and RE Botanicals Inc.

DEA 52

DEA – We’re Still Burnin’ Weed

Cannabis Law Report

A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More.

DEA 83

DEA Assisting “to the Maximum Extent Possible” in the Federal Law Enforcement Response to Nationwide Protests — NORML Responds

NORML

According to a DEA memorandum , the agency requested to expand its policing powers beyond the enforcement of federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.”

DEA 258

DEA Says It Will Finally Let Others Grow Research-Grade Cannabis

Leafly

Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research

DEA 87

DEA Sued By Rhode Island Lab Over ‘Foot Dragging’ On Marijuana Pharmaceutical Licensing

The Fresh Toast

DEA Sued By Rhode Island Lab Over ‘Foot Dragging’ On Marijuana Pharmaceutical Licensing. The post DEA Sued By Rhode Island Lab Over ‘Foot Dragging’ On Marijuana Pharmaceutical Licensing appeared first on The Fresh Toast.

DEA 56

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them.

DEA 101

Psychedelics Activists Protest Outside DEA’s Offices – Arrests Made

Cannabis Law Report

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Marijuana Moment reports.

DEA 52

Doctor Sues DEA for Right to Give Psilocybin to Ailing Patients

Project CBD

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice

DEA 259

ASA offers solution to DOJ research block: Our comments on the DEA’s proposed rules

Americans for Safe Access

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

Access 214

Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis?

Leafly

The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly.

DEA 86

It’s Time to Disband the DEA

Canna Law Blog

Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. Now, the DEA does not even need to suspect a drug crime has been committed to take action against protesters.

DEA 77

DEA Increases Access to Cannabis for Research Purposes

Veriheal

The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central. News Politics Research cannabis research cultivation DEA“Cannabis should remain illegal because more research is needed.

DEA 56

Court: DEA Must Explain Its Failure to Act Upon Pending Marijuana Cultivation Applications

NORML

” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research.

DEA loosens rules on prescription CBD drug Epidiolex

Leafly

The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals

DEA 102